bp retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Triple Hormone Receptor Agonist:

For most private patients, this is the more practical route - particularly where GP referrals for weight management remain limited

Companies are rarely transparent with patients or the public about the medical groups behind the screens

By week four of running both, the skin on my upper arms started firming up

Sleep disturbances & vivid dreams Some patients report intense dreaming, which typically resolves

The FDA has raised concerns about unapproved GLP-1 drugs used for weight loss, including fraudulent compounded products, dosing errors, and adverse event reports involving compounded semaglutide and tirzepatide.

These are commonly used to treat diabetes and to manage weight/ obesity (especially in those with diabetes) 1 Most GLP-1 agonist side effects occur because these medications change how the digestive system and appetite-regulating pathways work